Effect of clarithromycin on inflammatory markers in patients with atherosclerosis.

@article{Berg2003EffectOC,
  title={Effect of clarithromycin on inflammatory markers in patients with atherosclerosis.},
  author={Hans Fredrik Berg and Boulos Maraha and Gert-Jan Scheffer and Marcel F. Peeters and Jan Ajw Kluytmans},
  journal={Clinical and diagnostic laboratory immunology},
  year={2003},
  volume={10 4},
  pages={
          525-8
        }
}
Atherosclerosis can to a certain extent be regarded as an inflammatory disease. Also, inflammatory markers may provide information about cardiovascular risk. Whether macrolide antibiotics, especially clarithromycin, have an anti-inflammatory effect in patients with atherosclerosis is not exactly known. To study this phenomenon, a placebo-controlled, randomized, double-blind study was performed. A total of 231 patients with documented coronary artery disease received a daily dose of either 500… CONTINUE READING

References

Publications referenced by this paper.
SHOWING 1-10 OF 22 REFERENCES

Inflammatory markers at visits 1, 2, and 3 Marker and visit no. Treatment group (n) a Marker concn P value Mean SD CRP 1 Clarithromycin

S. Gupta, E. W. Leatham, +3 authors J. Tooze
  • Clarithromycin
  • 2003
VIEW 1 EXCERPT

Braunwald for the Cholesterol and Recurrent Events (CARE) Investigators

P. M. Ridker, N. Rifai, M. Pfeffer, F. Sacks, S. Lepage
  • Circulation
  • 2000
VIEW 1 EXCERPT

Clarithromycin suppresses bronchial hyperresponsiveness associated with eosinophilic inflammation in patients with asthma.

  • Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
  • 2000
VIEW 1 EXCERPT

Eleva - tion of tumour necrosis factor -  and increased risk of recurrent coronary events after myocardial infarction

N. Rifai
  • Circulation
  • 2000

Macrolides, asthma, inflammation, and infection.

  • Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
  • 2000
VIEW 1 EXCERPT